GlassScriptPhysician profile
Austin Healy
NPI 1104319409
$675.66
in general payments reported to CMS, 2019-2025
12 companies · $420 in 2025
The $420 reported for 2025 was more than what 90% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $106 · 2024: $150 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $152.49 | 2023-2024 | Jornay Pm |
| Integra Lifesciences Corporation | $141.42 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Stryker Corporation | $126.06 | 2025 | Smartlock |
| Collegium Pharmaceutical, INC. | $56.59 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $40.46 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Neurelis, INC. | $34.31 | 2023-2025 | Valtoco |
| Astrazeneca Pharmaceuticals LP | $30.18 | 2023 | Flumist Quadrivalent |
| Sanofi-Aventis U.S. LLC | $28.87 | 2025 | |
| Pfizer INC. | $18.09 | 2023 | |
| Motiva USA, LLC | $16.55 | 2025 | |
| Supernus Pharmaceuticals, INC. | $15.54 | 2025 | Qelbree |
| Verrica Pharmaceuticals INC. | $15.10 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Healy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.